Topic: Moderna

CHICAGO (Reuters) — A study of Moderna Inc’s COVID-19 vaccine in mice lends some assurance that it will not increase the risk of more severe disease, and that one dose may provide protection against the novel coronavirus, according[...]

By Denise Grady SEATTLE (New York Times) — The first testing in humans of an experimental vaccine for the new coronavirus began on Monday, March 16, the National Institute of Allergy and Infectious Diseases announced. The main goal of[...]